BeStock  
Stocks › OPCH

Option Care Health OPCH

US equityMarket cap rank #2373
$23.37 +$0.73 (+3.22%)
Market closed · Oct 6, 1:20 am ET · Last extended-hours $28.30 +21.10%
Open$22.55
Prev close$22.64
Day range$22.45 – $23.49
Volume2.82M
Market cap$3.50B
P/E (TTM)17.7
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025

Revenue$5.65B+13.0% YoY
Operating profit$337.91M+5.0% YoY
Net profit$207.59M-2.0% YoY
Diluted EPS$1.27+3.3% YoY
Free cash flow$172.52M+112.4% YoY
Operating cash flow$183.60M

Free cash flow by quarter

$150.7MSep '24$25.8MDec '24$-16.6MMar '25$81.2MJun '25$130.2MSep '25$22.2MDec '25$-21.2MMar '26$172.5MJun '26

Annual revenue

$3.0BFY20$3.4BFY21$3.9BFY22$4.3BFY23$5.0BFY24$5.6BFY25

Profitability & balance sheet

Gross margin19.3%
Operating margin6.0%
Net margin3.7%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Infusion Services$1.42B 98.2%
  • Other revenue$25.62M 1.8%

Cash flow

Line item 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2
Operating Cash Flow $183.60M -$12.11M $35.89M $139.44M $90.33M
-Change In Other Working Capital -$984,000.00 $382,000.00 $1.82M $3.96M -$495,000.00
-Change in Payables and Accrued Expense $93.24M -$98.08M $1.31M $49.72M $59.73M
-Change in Prepaid Assets -$11.19M $1.23M -$6.94M $7.09M -$10.84M
-Change in Inventory $16.08M $55.46M -$56.57M -$12.18M -$34.51M
-Change in Receivables $4.93M -$42.87M $837,000.00 $5.96M -$4.60M
Change in Working Capital $96.39M -$89.73M -$65.45M $49.03M $4.64M
Other Non-Cash Items $6.10M $6.25M $7.41M $6.54M $7.03M
Deferred Tax $1.04M $1.87M $6.00M $809,000.00 $264,000.00
Depreciation & Depletion & Amortization $18.38M $15.66M $20.32M $17.05M $16.95M
Gain/Loss from Continuing Operations -$1.70M -$1.69M -$2.11M $2.57M -$1.40M
Net Income from Continuing Operations $53.91M $45.34M $58.50M $51.82M $50.52M
Net cash flow from continuing operations $183.60M -$12.11M $35.89M $139.44M $90.33M
Net cash flow from investing -$11.68M -$9.32M -$13.65M -$11.72M -$9.02M
Net Cash Flow from Continuing Investing Activities -$11.68M -$9.32M -$13.65M -$11.72M -$9.02M
Net PPE Purchase and Sale -$11.08M -$9.05M -$13.65M -$9.20M -$9.10M
-Change in Other Current Liabilities -$5.68M -$5.86M -$5.92M -$5.52M -$4.65M
Free Cash Flow $172.52M -$21.16M $22.25M $130.24M $81.24M
Beginning Cash Balance $177.32M $232.62M $309.82M $198.82M $171.37M
Net Change in Cash $16.45M -$55.30M -$77.20M $111.00M $27.45M
Ending Cash Balance $193.77M $177.32M $232.62M $309.82M $198.82M
Net Other Financing Charges $922,000.00 -$2.04M $180.24M -$183.71M $482,000.00
Proceeds from Stock Option Exercised -$1.69M -$12.60M -$2.68M -$16,000.00 -$515,000.00
Net Common Stock Issuance -$153.01M -$17.54M -$95.06M -$62.46M -$52.21M
Net Business Purchase and Sale $0.00 $0.00 $0.00 $0.00 $75,000.00
Net Other Investing Changes -$603,000.00 -$274,000.00 $0.00 – –
Financing Cash Flow -$155.47M -$33.87M -$99.44M -$16.71M -$53.87M
Net Cash Flow from Continuing Financing Activities -$155.47M -$33.87M -$99.44M -$16.71M -$53.87M
Net Issuance Payments Of Debt -$1.70M -$1.70M -$181.94M $229.47M -$1.63M

Income statement

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Profit from Continuing Operations $207.59M $211.82M $267.09M $150.56M $139.90M
Tax $75.32M $71.78M $91.65M $55.21M -$23.40M
Pretax Profit $282.90M $283.60M $358.74M $205.77M $116.49M
Other Non-Operating Income (Expenses) -$7.86M $4.83M $89.87M $14.22M -$13.37M
Net Income to Parent Company $207.59M $211.82M $267.09M $150.56M $139.90M
Net Income to Common Stockholders $207.59M $211.82M $267.09M $150.56M $139.90M
Diluted EPS $1.27 $1.23 $1.48 $0.83 $0.77
Earnings from Equity Interest $7.41M $5.96M $5.53M $5.13M $6.03M
Other Income (Expense) -$448,000.00 $10.80M $95.40M $19.34M -$7.34M
Non-Operating Interest Expense $54.56M $49.03M $51.25M $53.81M $67.00M
Net Non-Operating Interest Income (Expense) -$54.56M -$49.03M -$51.25M -$53.81M -$67.00M
Net Profit $207.59M $211.82M $267.09M $150.56M $139.90M
Basic EPS $1.28 $1.23 $1.49 $0.83 $0.78
Total Revenue as Reported $5.65B $5.00B $4.30B $3.94B $3.44B
Total Operating Revenue $5.65B $5.00B $4.30B $3.94B $3.44B
Cost of Revenue $4.56B $3.99B $3.32B $3.08B $2.66B
Gross Profit $1.09B $1.01B $981.22M $866.92M $779.61M
Operating Expense $749.99M $691.16M $666.63M $626.69M $588.77M
Selling and Admin Expenses $682.45M $630.25M $607.43M $566.12M $525.71M
Depreciation & Amortization & Depletion $67.54M $60.91M $59.20M $60.57M $63.06M
-Depreciation & Amortization $67.54M $60.91M $59.20M $60.57M $63.06M
Operating Profit $337.91M $321.83M $314.60M $240.23M $190.84M

Discussion

No comments yet — be the first to weigh in on OPCH.

Leave a comment

Scroll to Top